Marcus Weitz

Marcus Weitz

Auto-generated profile, based on publicly available information

Marcus Weitz

Abteilung Allgemeine Pädiatrie und Hämatologie/Onkologie, Universitätskinderklinik Tübingen, Tübingen, Deutschland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
MWMarcus Weitz
Marcus Weitz
OAOliver Amon
Oliver Amon
DBDirk Bassler
Dirk Bassler
AKAlfred Koenigsrainer
Alfred Koenigsrainer
SNSilvio Nadalin
Silvio Nadalin

25 January 2016 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SNSamuel Nef
Samuel Nef
TNThomas J. Neuhaus
Thomas J. Neuhaus
GSGiuseppina Spartà
Giuseppina Spartà
MWMarcus Weitz
Marcus Weitz
KBKathrin Buder
Kathrin Buder
GLGuido F. Laube
Guido F. Laube

11 August 2015 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
MWMarcus Weitz
Marcus Weitz
SHSaskia Heeringa
Saskia Heeringa
TNThomas J. Neuhaus
Thomas J. Neuhaus
TFThomas Fehr
Thomas Fehr
GLGuido F. Laube
Guido F. Laube

23 December 2016 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
MWMarcus Weitz
Marcus Weitz
MSMaria Schmidt
Maria Schmidt
GLGuido Laube
Guido Laube

25 November 2016 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
MWMarcus Weitz
Marcus Weitz
MSMaria Schmidt
Maria Schmidt

30 April 2019 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
EPEvgenia Preka
Evgenia Preka
MBMarjolein Bonthuis
Marjolein Bonthuis
JHJerome Harambat
Jerome Harambat
KJKitty J Jager
Kitty J Jager
JGJaap W Groothoff
Jaap W Groothoff
SESEVCAN AZIME BAKKALOGLU EZGU
SEVCAN AZIME BAKKALOGLU EZGU
Background: There is no consensus regarding the timing of dialysis therapy initiation for end-stage kidney disease (ESKD) in children. As studies investigating the association between timing of dialysis initiation and clinical outcomes are lacking, we aimed to study this relationship in a cohort of European children who started maintenance dialysis treatment.Methods: We used data on 2963 children from 21 different countries included in the European Society of Pediatric Nephrology/European Renal Association–European Dialysis and Transplant Association Registry who started renal replacement therapy before 18 years of age between 2000 and 2014. We compared two groups according to the estimated glomerular filtration rate (eGFR) at start: eGFR ≥8 mL/min/1.73 m2 (early starters) and eGFR <8 mL/min/1.73 m2 (late starters). The primary outcomes were patient survival and access to transplantation. Secondary outcomes were growth and cardiovascular risk factors. Sensitivity analyses were performed to account for selection- and lead time-bias.Results: The median eGFR at the start of dialysis was 6.1 for late versus 10.5 mL/min/1.73 m2 for early starters. Early starters were older [median: 11.0, interquartile range (IQR): 5.7–14.5 versus 9.4, IQR: 2.6–14.1 years]. There were no differences observed between the two groups in mortality and access to transplantation at 1, 2 and 5 years of follow-up. One-year evolution of height standard deviation scores was similar among the groups, whereas hypertension was more prevalent among late initiators. Sensitivity analyses resulted in similar findings.Conclusions: We found no evidence for a clinically relevant benefit of early start of dialysis in children with ESKD. Presence of cardiovascular risk factors, such as high blood pressure, should be taken into account when deciding to initiate or postpone dialysis in children with ESKD, as this affects the survival.